ORIENTAL AROMATICS LTD
Updated
The global Camphor market size was valued at USD 479.39 million in 2021 and is expected to expand at a CAGR of 3.92 (Percent) during the forecast period, reaching USD 603.63 million by 2027.
List of Indian TOP Manufactures in Camphor Market are: -
● Kanchi Karpooram
● Camphor and Allied Products ( Oriental Aromatics LTD)
● Mangalam Organics
● Sapthagiri Camphor ( Unlisted)
- Among above 3 Listed scripts OAL and KANCHI shortlisted , Since OAL business is diversified its less risky , But Based on funadmentals Kanchi Karpooram is attractive /Cheap to buy.
Market Cap
₹ 1,361 Cr.
Current Price
₹ 404
Stock P/E
224
Book Value
₹ 186
Dividend Yield
0.14 %
ROCE
5.19 %
ROE
3.35 %
Face Value
₹ 5.00
Promoter holding
74.2 %
EPS last year
₹ 6.13
EPS latest quarter
₹ -1.76
Debt
₹ 231 Cr.
Pledged percentage
0.00 %
Net CF
₹ 3.33 Cr.
Price to Cash Flow
-64.0
Free Cash Flow
₹ -57.1 Cr.
Debt to equity
0.37
OPM last year
6.46 %
OPM 5Year
13.9 %
Reserves
₹ 610 Cr.
Price to book value
2.16
Int Coverage
1.59
PEG Ratio
-29.6
Price to Sales
1.68
Market Cap to Sales
1.68
Qtr Profit Var
-169 %
List of Indian TOP Manufactures in Camphor Market are: -
● Kanchi Karpooram
● Camphor and Allied Products ( Oriental Aromatics LTD)
● Mangalam Organics
● Sapthagiri Camphor ( Unlisted)
- Among above 3 Listed scripts OAL and KANCHI shortlisted , Since OAL business is diversified its less risky , But Based on funadmentals Kanchi Karpooram is attractive /Cheap to buy.
Market Cap
₹ 1,361 Cr.
Current Price
₹ 404
Stock P/E
224
Book Value
₹ 186
Dividend Yield
0.14 %
ROCE
5.19 %
ROE
3.35 %
Face Value
₹ 5.00
Promoter holding
74.2 %
EPS last year
₹ 6.13
EPS latest quarter
₹ -1.76
Debt
₹ 231 Cr.
Pledged percentage
0.00 %
Net CF
₹ 3.33 Cr.
Price to Cash Flow
-64.0
Free Cash Flow
₹ -57.1 Cr.
Debt to equity
0.37
OPM last year
6.46 %
OPM 5Year
13.9 %
Reserves
₹ 610 Cr.
Price to book value
2.16
Int Coverage
1.59
PEG Ratio
-29.6
Price to Sales
1.68
Market Cap to Sales
1.68
Qtr Profit Var
-169 %
Trade active
Target 2 Done
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.